M Lindh

Summary

Country: Sweden

Publications

  1. ncbi Virological response to interferon therapy of chronic hepatitis B as measured by a highly sensitive assay
    M Lindh
    Department of Clinical Virology, Goteborg University, Goteborg, Sweden
    J Viral Hepat 8:349-57. 2001
  2. ncbi Genotype mixtures of hepatitis B virus in patients treated with interferon
    Charles Hannoun
    Department of Clinical Virology, , , Sweden
    J Infect Dis 186:752-9. 2002
  3. ncbi Dichotomy of glycoprotein g gene in herpes simplex virus type 1 isolates
    Elham Rekabdar
    Department of Clinical Virology, Goteborg University, Goteborg, Sweden
    J Clin Microbiol 40:3245-51. 2002
  4. ncbi Comparison of HIV-1 pol and env sequences of blood, CSF, brain and spleen isolates collected ante-mortem and post-mortem
    E C Caragounis
    Department of Clinical Virology, The Sahlgrenska Academy at Goteborg University, Gothenburg, Sweden
    Acta Neurol Scand 117:108-16. 2008
  5. ncbi High cytokine levels in perforated acute otitis media exudates containing live bacteria
    S Skovbjerg
    Department of Infectious Medicine Clinical Bacteriology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden
    Clin Microbiol Infect 16:1382-8. 2010
  6. ncbi Dynamic tailoring of treatment durations improves efficiency of hepatitis C treatment with pegylated interferon and ribavirin
    M Lindh
    Department of Infectious Diseases, University of Gothenburg, Gothenburg, Sweden
    J Viral Hepat 20:e82-9. 2013
  7. ncbi Access to a polymerase chain reaction assay method targeting 13 respiratory viruses can reduce antibiotics: a randomised, controlled trial
    Robin Brittain-Long
    Department of Infectious Diseases, Sahlgrenska University Hospital, Smörslottsgatan 1, Gothenburg, Sweden
    BMC Med 9:44. 2011
  8. ncbi Real-time PCR detection of human herpesvirus 1-5 in patients lacking clinical signs of a viral CNS infection
    Birgitta Sundén
    Div Clinical Microbiology, Department of Clinical and Experimental Medicine, Linkoping University, Sweden
    BMC Infect Dis 11:220. 2011
  9. ncbi Core mutations, IL28B polymorphisms and response to peginterferon/ribavirin treatment in Swedish patients with hepatitis C virus genotype 1 infection
    Erik Alestig
    Department of Infection and Virology, University of Gothenburg, Gothenburg, Sweden
    BMC Infect Dis 11:124. 2011
  10. ncbi Monitoring treatment response by the hepatitis C virus core antigen assay
    M Lindh
    Department of Clinical Virology, , Guldhedsgatan 10B, 41346, , Sweden
    Eur J Clin Microbiol Infect Dis 24:230-2. 2005

Collaborators

Detail Information

Publications58

  1. ncbi Virological response to interferon therapy of chronic hepatitis B as measured by a highly sensitive assay
    M Lindh
    Department of Clinical Virology, Goteborg University, Goteborg, Sweden
    J Viral Hepat 8:349-57. 2001
    ..0 (PPV=92%). The potential value of differentiating the therapy of chronic hepatitis B on the basis of viraemia levels, as measured by highly sensitive assays, should be further investigated...
  2. ncbi Genotype mixtures of hepatitis B virus in patients treated with interferon
    Charles Hannoun
    Department of Clinical Virology, , , Sweden
    J Infect Dis 186:752-9. 2002
    ..This should be considered when tracing the source of HBV infection...
  3. ncbi Dichotomy of glycoprotein g gene in herpes simplex virus type 1 isolates
    Elham Rekabdar
    Department of Clinical Virology, Goteborg University, Goteborg, Sweden
    J Clin Microbiol 40:3245-51. 2002
    ....
  4. ncbi Comparison of HIV-1 pol and env sequences of blood, CSF, brain and spleen isolates collected ante-mortem and post-mortem
    E C Caragounis
    Department of Clinical Virology, The Sahlgrenska Academy at Goteborg University, Gothenburg, Sweden
    Acta Neurol Scand 117:108-16. 2008
    ..The aim of this study was to investigate HIV-1 evolution in the CNS and the origin of HIV-1 in CSF...
  5. ncbi High cytokine levels in perforated acute otitis media exudates containing live bacteria
    S Skovbjerg
    Department of Infectious Medicine Clinical Bacteriology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden
    Clin Microbiol Infect 16:1382-8. 2010
    ..IL-6 and PGE2, however, remain after bacterial disintegration, and may play a role in the resolution phase...
  6. ncbi Dynamic tailoring of treatment durations improves efficiency of hepatitis C treatment with pegylated interferon and ribavirin
    M Lindh
    Department of Infectious Diseases, University of Gothenburg, Gothenburg, Sweden
    J Viral Hepat 20:e82-9. 2013
    ..The outcome parameter treatment weeks per cured patient could become a useful tool for comparing treatment efficiency also in the era of directly acting antivirals...
  7. ncbi Access to a polymerase chain reaction assay method targeting 13 respiratory viruses can reduce antibiotics: a randomised, controlled trial
    Robin Brittain-Long
    Department of Infectious Diseases, Sahlgrenska University Hospital, Smörslottsgatan 1, Gothenburg, Sweden
    BMC Med 9:44. 2011
    ....
  8. ncbi Real-time PCR detection of human herpesvirus 1-5 in patients lacking clinical signs of a viral CNS infection
    Birgitta Sundén
    Div Clinical Microbiology, Department of Clinical and Experimental Medicine, Linkoping University, Sweden
    BMC Infect Dis 11:220. 2011
    ..The aim of this study was to investigate if herpes- or enterovirus can be detected in cerebrospinal fluid (CSF) from patients without symptoms...
  9. ncbi Core mutations, IL28B polymorphisms and response to peginterferon/ribavirin treatment in Swedish patients with hepatitis C virus genotype 1 infection
    Erik Alestig
    Department of Infection and Virology, University of Gothenburg, Gothenburg, Sweden
    BMC Infect Dis 11:124. 2011
    ..In the present study, the impact of these mutations on response kinetics and treatment outcome was explored in Caucasian patients...
  10. ncbi Monitoring treatment response by the hepatitis C virus core antigen assay
    M Lindh
    Department of Clinical Virology, , Guldhedsgatan 10B, 41346, , Sweden
    Eur J Clin Microbiol Infect Dis 24:230-2. 2005
  11. ncbi Dynamic range and reproducibility of hepatitis B virus (HBV) DNA detection and quantification by Cobas Taqman HBV, a real-time semiautomated assay
    Magnus Lindh
    Department of Clinical Virology, Goteborg University, Guldhedsgatan 10B, 413 46 Goteborg, Sweden
    J Clin Microbiol 43:4251-4. 2005
    ..The coefficient of variation was 1.2% at > or =1,000 IU/ml and 22.0% at 10 IU/ml. In 97 clinical samples, the log HBV DNA/ml differed by 0.11 between Cobas Amplicor and Cobas Taqman (r2 = 0.97)...
  12. ncbi Genotyping of hepatitis C virus by Taqman real-time PCR
    Magnus Lindh
    Department of Clinical Virology, Guldhedsgatan 10 B, 413 46 Goteborg, Sweden
    J Clin Virol 34:108-14. 2005
    ..Genotype of hepatitis C virus (HCV) is of major importance for the outcome of treatment. The response rate is considerably lower for genotype 1, the predominant genotype in western countries...
  13. ncbi Lamivudine resistance of hepatitis B virus masked by coemergence of mutations in probe region of the COBAS AMPLICOR assay
    Magnus Lindh
    Department of Clinical Virology, Goteborg University, Guldhedsgatan 10 B, 413 46 Goteborg, Sweden
    J Clin Microbiol 44:2587-9. 2006
    ..However, the assay failed to recognize increasing viremia levels when YMDD mutations were paralleled by mutations in the segment targeted by the COBAS AMPLICOR probe...
  14. ncbi Real-time Taqman PCR targeting 14 human papilloma virus types
    Magnus Lindh
    Department of Virology, The Sahlgrenska Academy, Goteborg University, Sweden
    J Clin Virol 40:321-4. 2007
    ..Subtyping of human papilloma virus (HPV) may enhance the precision of vaginal cytological assessments and will be important for investigating the effect of the recently introduced vaccine against types 16 and 18...
  15. ncbi IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1
    M Lindh
    Department of Infectious Diseases, University of Gothenburg, Gothenburg, Sweden
    J Viral Hepat 18:e325-31. 2011
    ..A combined assessment of these SNPs in conjunction with other response predictors may better predict outcome in difficult-to-treat patients...
  16. ncbi Novel method for genotyping hepatitis B virus on the basis of TaqMan real-time PCR
    Sebastian Malmström
    Department of Infectious Diseases, Section for Clinical Virology, Guldhedsgatan 10 B, 413 46 Goteborg, Sweden
    J Clin Microbiol 48:1105-11. 2010
    ..We conclude that this new assay represents a significant advancement for both diagnostics and clinical research because it is accurate, practical, and based on a technique that is well established in many virological laboratories...
  17. ncbi Interleukin 28B gene variation at rs12979860 determines early viral kinetics during treatment in patients carrying genotypes 2 or 3 of hepatitis C virus
    Magnus Lindh
    Department of Infectious Diseases, University of Gothenburg, Sweden
    J Infect Dis 203:1748-52. 2011
    ..The results indicate that IL28B gene testing may identify patients carrying genotype 2 or 3 who could benefit from extended treatment...
  18. ncbi Response prediction and treatment tailoring for chronic hepatitis C virus genotype 1 infection
    Magnus Lindh
    Department of Infection and Virology, Sahlgrenska Academy, Goteborg University, Goteborg, Sweden
    J Clin Microbiol 45:2439-45. 2007
    ..On the basis of these findings, we propose a model of tailored treatment which takes into account the second-phase slope and the amount of HCV RNA after 21 days of treatment...
  19. ncbi Mutation of nucleotide 1,762 in the core promoter region during hepatitis B e seroconversion and its relation to liver damage in hepatitis B e antigen carriers
    M Lindh
    Department of Clinical Virology, Goteborg University, Sweden
    J Med Virol 55:185-90. 1998
    ..The presence of a T-1,762 mutant in the HBeAg+ phase may be useful for identifying immunoactivation in previously immunotolerant carriers, which could be valuable for selecting patients for interferon therapy...
  20. ncbi Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon
    M Lindh
    Department of Clinical Virology, Goteborg University, Sweden
    J Virol Methods 72:163-74. 1998
    ..This method should be useful for epidemiological investigations and for studying the potential influence of genotype on the course of infection...
  21. ncbi Treatment of chronic hepatitis B infection: an update of Swedish recommendations
    Magnus Lindh
    Department of Infectious Diseases, Sahlgrenska University Hospital, Goteborg, Sweden
    Scand J Infect Dis 40:436-50. 2008
    ..mpa.se and www.rav.nu.se) including 7 separate papers based on thorough literature search. The complete reference list can be received from the Medical Products Agency upon request...
  22. ncbi Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers
    M Lindh
    Department of Clinical Virology, Goteborg University, S 413 46 Goteborg, Sweden
    J Infect Dis 179:775-82. 1999
    ....
  23. ncbi Acute hepatitis B in Western Sweden--genotypes and transmission routes
    M Lindh
    Dept of Clinical Virology, Goteborg University, Sweden
    Infection 28:161-3. 2000
    ....
  24. ncbi Hepatitis C treatment response kinetics and impact of baseline predictors
    M Lindh
    Department of Infectious Diseases, University of Gothenburg, Gothenburg, Sweden
    J Viral Hepat 18:400-7. 2011
    ..The kinetic patterns and the high relapse rate in genotype 2/3 patients without RVR suggest that this group might benefit from treatment durations longer than 24weeks...
  25. ncbi Monitoring virological responses to interferon-ribavirin and interferon monotherapy of chronic hepatitis C re-treated due to relapse or non-response
    J Westin
    Department of Infectious Diseases, Sahlgrenska University Hospital, , Sweden
    Scand J Infect Dis 33:110-5. 2001
    ..Loss of viremia at week 4 of IFN was associated with a sustained response to IFN-RBV and was seen in 11 of 13 patients (85%) with genotypes 2 or 3, as compared with one of seven patients (14%) with genotype 1 (p = 0.0044)...
  26. ncbi Phylogenetic origin of hepatitis B virus strains with precore C-1858 variant
    E Alestig
    Department of Clinical Virology, , , Sweden
    J Clin Microbiol 39:3200-3. 2001
    ..Further study of the distribution of this variant is warranted...
  27. ncbi Hepatitis B virus genotypes in Mongols and Australian Aborigines
    E Alestig
    Department of Clinical Virology, , Sweden
    Arch Virol 146:2321-9. 2001
    ..By preS analysis, they were however clearly of genotype C. The 6-7% nucleotide difference from published Asian genotype C sequences suggests that they diverged from Asian genotype C branch more than 1000 years ago...
  28. ncbi Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection
    Johan Westin
    Department of Infectious Diseases, Goteborg University, Göteborg Sweden
    J Viral Hepat 9:235-41. 2002
    ..From that point of view, total abstention ought to be recommended. If this is not achieved, occasional use of alcohol is probably less harmful than daily drinking for patients with low or moderate alcohol consumption...
  29. ncbi Histologic activity of childhood chronic hepatitis B related to viremia levels, genotypes, mutations, and epidemiologic factors
    Ann Soderstrom
    Department of Infectious Diseases, Goteborg University, Sweden
    J Pediatr Gastroenterol Nutr 35:487-94. 2002
    ..Despite the absence of biochemical abnormalities in these patients, there is still a risk for long-term complications. The pathogenic importance of viral load and genetic variability is less well studied in children than in adults...
  30. ncbi Mutations in the X region and core promoter are rare and have little impact on response to interferon therapy for chronic hepatitis B
    Charles Hannoun
    Department of Clinical Virology, , , Sweden
    J Med Virol 66:171-8. 2002
    ..The low frequency of mutations indicates that analysis of this region is of limited clinical value and that emerging mutations in this region are not major determinants of response to treatment with IFN-alpha...
  31. ncbi Simple method for detection of mutations causing hereditary fructose intolerance
    C Kullberg-Lindh
    Department of Pediatrics, Goteborg University, Sweden
    J Inherit Metab Dis 25:571-5. 2002
    ..The method might be useful for screening of these mutations, which may account for more than 70% of the mutations causing HFI...
  32. ncbi Opportunistic virus DNA levels after pediatric stem cell transplantation: serostatus matching, anti-thymocyte globulin, and total body irradiation are additive risk factors
    C Kullberg-Lindh
    Department of Paediatrics, Sahlgrenska Academy, University of Gothenburg, Goteborg, Sweden
    Transpl Infect Dis 13:122-30. 2011
    ..We conclude that DNAemia levels help to distinguish significant viral infections, and that surveillance and prophylactic measures should be focused on patients with risk factors in whom viral complications rapidly can become fatal...
  33. ncbi Treatment of hepatitis C virus infection: updated Swedish Consensus recommendations
    Martin Lagging
    Department of Infectious Diseases and Virology, Sahlgrenska University Hospital, Goteborg
    Scand J Infect Dis 41:389-402. 2009
    ..For liver transplant patients pre-emptive therapy is not recommended; hence, treatment should be deferred until histological recurrence...
  34. ncbi Varicella-zoster virus CNS disease--viral load, clinical manifestations and sequels
    Anna Persson
    Department of Infectious Diseases, Sahlgrenska University Hospital, Ostra, SE 416 85, Gothenburg, Sweden
    J Clin Virol 46:249-53. 2009
    ..The VZV viral load in the CSF obtained from VZV-related neurological syndromes is not known...
  35. ncbi Phylogenetic analysis of clinical herpes simplex virus type 1 isolates identified three genetic groups and recombinant viruses
    Peter Norberg
    Department of Virology, University of Goteborg, Guldhedsgatan 10 B, S 413 46 Goteborg, Sweden
    J Virol 78:10755-64. 2004
    ..The presence of polymorphic tandem repeat regions and the different genogroup identities can be used for molecular epidemiology studies and for further detection of recombination in the HSV-1 genome...
  36. ncbi A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: role of NADPH oxidase-derived oxygen radicals
    Fredrik Thoren
    Department of Clinical Virology, Goteborg University, Guldhedsgatan 10B, S 413 46 Goteborg, Sweden
    J Leukoc Biol 76:1180-6. 2004
    ....
  37. ncbi Detection and typing of Herpes Simplex virus (HSV) in mucocutaneous samples by TaqMan PCR targeting a gB segment homologous for HSV types 1 and 2
    Lilly Namvar
    Department of Clinical Virology, , Guldhedsgatan 10B, , Sweden
    J Clin Microbiol 43:2058-64. 2005
    ..HSV-1 constituted 40% of genital infections and was associated with lower mean age (29.2 versus 36.4 years), probably reflecting the fact that recurrent genital HSV-1 infections are rare...
  38. ncbi Mutation analysis of lamivudine resistant hepatitis B virus strains by TaqMan PCR
    Sebastian Malmström
    Department of Clinical Virology, Goteborg University, Guldhedsgatan 10 B, 413 46 Goteborg, Sweden
    J Virol Methods 143:147-52. 2007
    ..This method is rapid, cost effective, and should prove useful for monitoring patients treated with lamivudine...
  39. ncbi Comparison of serum and whole blood levels of cytomegalovirus and Epstein-Barr virus DNA
    C Kullberg-Lindh
    Department of Paediatrics, Queen Silvia Children s Hospital, Goteborg University, Goteborg, Sweden
    Transpl Infect Dis 10:308-15. 2008
    ..Identification of PTLD may require EBV DNA testing in both specimen types or complementary tests...
  40. ncbi Progression of fibrosis in untreated patients with hepatitis C virus infection
    L Martin Lagging
    Department of Clinical Virology, Goteborg University, Goteborg, Sweden, Department of Infectious Diseases, Goteborg University, Sweden
    Liver 22:136-44. 2002
    ..If moderate interface hepatitis early in the course of the disease is followed by less interface hepatitis later there is less fibrosis; and if moderate interface hepatitis persists, there is more fibrosis eventually...
  41. ncbi Predictive factors and virological response to interferon treatment in children with chronic hepatitis B
    Ann Soderstrom
    Department of Infectious Diseases, Goteborg University, Sweden
    Scand J Infect Dis 37:40-7. 2005
    ..Thus, pretreatment HBV DNA levels were associated with IFN response, and the virological response at week 12 predicts SR and may be useful in the decision to continue or modify therapy...
  42. ncbi Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time
    L Martin Lagging
    Department of Clinical Virology, Goteborg University, Goteborg, Sweden
    J Clin Microbiol 40:4224-9. 2002
    ..0 years) and 4.41 for the sera obtained at the time of the second biopsy (median storage time, 6.6 years) compared to 5.96, the median for 102 different routine clinical patient samples...
  43. ncbi Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission
    Ann Soderstrom
    Department of Infectious Diseases, Sahlgrenska University Hospital, Ostra, Goteborg, Sweden
    Scand J Infect Dis 35:814-9. 2003
    ..Vertical transmission was only seen in HBeAg-positive mothers with very high levels of viremia. The value of measuring HBV DNA in the pregnant woman to modify immunoprophylaxis to her infant needs further study...
  44. ncbi Epstein-Barr viremia levels after pediatric liver transplantation as measured by real-time polymerase chain reaction
    Carola Kullberg-Lindh
    Department of Pediatrics, Queen Silvia Children s Hospital, Goteborg, Sweden
    Pediatr Transplant 10:83-9. 2006
    ..The data suggest that quantitative analysis of EBV DNA in serum by real-time PCR is useful for identification of EBV-related disease...
  45. ncbi Nosocomial transmission of HCV in a cardiology ward during the window phase of infection: an epidemiological and molecular investigation
    L Martin Lagging
    Department of Infectious Diseases, Goteborg University, Sweden
    Scand J Infect Dis 34:580-2. 2002
    ..It may, therefore, be prudent to restrict the use of such vials, in addition to promoting vigorous adherence to standard hygiene procedures in order to prevent the recurrence of similar outbreaks in the future...
  46. ncbi Excess mortality following community-onset norovirus enteritis in the elderly
    L Gustavsson
    Department of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden
    J Hosp Infect 79:27-31. 2011
    ..001). In conclusion, community-onset NVE requiring hospitalization was associated with higher mortality compared with hospital-onset NVE and matched controls in hospitalized elderly patients...
  47. ncbi Real time PCR for monitoring regulation of host gene expression in herpes simplex virus type 1-infected human diploid cells
    Kristina Nyström
    Clinical Virology, University of Goteborg, Guldhedsgatan 10B, S 413 46 Goteborg, Sweden
    J Virol Methods 118:83-94. 2004
    ..By applying these procedures, it was shown that the transcription of FUT5 was increased by 50-fold 5-24h after HSV-1 infection and 200-fold by the inhibition of viral DNA replication in HSV-infected cells...
  48. ncbi Quantitative analysis of CMV DNA in children the first year after liver transplantation
    Carola Kullberg-Lindh
    Departments of Pediatrics and Clinical Virology, Goteborg University, Goteborg, Sweden
    Pediatr Transplant 7:296-301. 2003
    ..The data suggest that quantitative analysis of CMV DNA may be of value in early identification of CMV disease and for avoiding unnecessary antiviral treatment...
  49. ncbi Neutralization of pseudotyped vesicular stomatitis virus expressing hepatitis C virus envelope glycoprotein 1 or 2 by serum from patients
    L Martin Lagging
    Department of Clinical Virology, Goteborg University, Guldhedsgatan 10B, S 413 46 Goteborg, Sweden
    J Infect Dis 185:1165-9. 2002
    ....
  50. ncbi Oxygen radical production and severity of the Guillain--Barré syndrome
    Natalia Mossberg
    Department of Neuroscience and Physiology, Sahlgrenska University Hospital, Goteborg, Sweden
    J Neuroimmunol 192:186-91. 2007
    ....
  51. ncbi Phylogeny of African complete genomes reveals a West African genotype A subtype of hepatitis B virus and relatedness between Somali and Asian A1 sequences
    Charles Hannoun
    Department of Clinical Virology, , Guldhedsgatan 10B, , Sweden
    J Gen Virol 86:2163-7. 2005
    ....
  52. ncbi Multiplex real-time PCR for detection of respiratory tract infections
    Robin Brittain-Long
    Department of Infection, The Sahlgrenska Academy, Goteborg University, 416 85 Goteborg, Sweden
    J Clin Virol 41:53-6. 2008
    ..Broad diagnostics of respiratory infection by molecular assays has not yet won acceptance due to technical difficulties and high costs...
  53. ncbi Excellent booster response 4 to 8 years after a single primary dose of an inactivated hepatitis A vaccine
    Sten Iwarson
    Department of Infectious Diseases, Sahlgrenska University Hospital, , Sweden
    J Travel Med 11:120-1. 2004
  54. ncbi Virus-induced transcriptional activation of host FUT genes associated with neo-expression of Ley in cytomegalovirus-infected and sialyl-Lex in varicella-zoster virus-infected diploid human cells
    Kristina Nyström
    Department of Virology, University of Goteborg, Goteborg, Sweden
    Glycobiology 17:355-66. 2007
    ..The induced carbohydrate antigens in CMV- and VZV-infected cells could be of significance for virus spread and possible escape from immune responses...
  55. ncbi Prospective evaluation of a novel multiplex real-time PCR assay for detection of fifteen respiratory pathogens-duration of symptoms significantly affects detection rate
    Robin Brittain-Long
    Department of Infectious Diseases, Sahlgrenska University Hospital, Ostra, Gothenburg, Sweden
    J Clin Virol 47:263-7. 2010
    ..We have evaluated a multiplex real-time PCR method for the detection of 13 respiratory viruses and 2 bacteria (Mycoplasma and Chlamydophila) in a clinical setting...
  56. ncbi Demonstration of an association between detection of IgG antibody reactivity towards the C-terminal region of the preS1 protein of hepatitis B virus and the capacity to respond to interferon therapy in chronic hepatitis B
    Ulla Hellstrom
    Department of Communicable Disease Control and Prevention, Karolinska Hospital, Stockholm, Sweden
    J Gastroenterol Hepatol 23:804-10. 2008
    ....
  57. ncbi Simultaneous quantification and genotyping of hepatitis B virus for genotypes A to G by real-time PCR and two-step melting curve analysis
    Wen-Chun Liu
    Institute of Basic Medical Sciences, Department of Medicine, National Cheng Kung University, Tainan City 704, Taiwan, Republic of China, and Liver Unit, Hospital General Universitari Vall d'Hebron, Barcelona, Spain
    J Clin Microbiol 44:4491-7. 2006
    ..3% of 441 samples were accurately genotyped by the current assay. The method should be useful for genotyping and quantification of HBV DNA in areas where all genotypes exist...
  58. ncbi HBV genotype G-an odd genotype of unknown origin
    Magnus Lindh
    J Clin Virol 34:315-6. 2005